Integra Lifesciences Holdings Corp (IART) — 10-Q Filings
All 10-Q filings from Integra Lifesciences Holdings Corp. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Integra LifeSciences Swings to $515M Loss on Goodwill Impairment
— Oct 30, 2025 Risk: high
Integra LifeSciences Holdings Corp (IART) reported a significant net loss of $514.77 million for the nine months ended September 30, 2025, a substantial increas -
Integra LifeSciences Swings to Q2 Loss Amid Rising Costs
— Jul 31, 2025 Risk: high
Integra LifeSciences Holdings Corp. reported a net loss of $1.5 million for the three months ended June 30, 2025, a significant decline from a net income of $22 -
Integra LifeSciences Files Q1 2025 10-Q
— May 5, 2025 Risk: low
Integra LifeSciences Holdings Corp. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for th -
Integra LifeSciences Files Q3 2024 10-Q
— Nov 4, 2024 Risk: medium
Integra LifeSciences Holdings Corp. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates fo -
Integra LifeSciences Files 10-Q for Q2 2024
— Jul 29, 2024 Risk: medium
Integra LifeSciences Holdings Corp. reported its financial results for the period ending June 30, 2024. The company's filing indicates a fiscal year end of Dece -
Integra Lifesciences Holdings Corp. Files 10-Q for Period Ending March 31, 2024
— May 6, 2024 Risk: low
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) filed a Quarterly Report (10-Q) with the SEC on May 6, 2024. Integra Lifesciences Holdings Corp. filed a 10-Q report f
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX